1Department of Neurosurgery, Baylor College of Medicine.
2Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston; and.
Neurosurg Focus. 2022 Apr;52(4):E8. doi: 10.3171/2022.1.FOCUS21708.
Vestibular schwannomas (VSs) are the most common neoplasm of the cerebellopontine angle in adults. Though these lesions are generally slow growing, their growth patterns and associated symptoms can be unpredictable, which may complicate the decision to pursue conservative management versus active intervention. Additionally, surgical decision-making can be controversial because of limited high-quality evidence and multiple quality-of-life considerations. Machine learning (ML) is a powerful tool that utilizes data sets to essentialize multidimensional clinical processes. In this study, the authors trained multiple tree-based ML algorithms to predict the decision for active treatment versus MRI surveillance of VS in a single institutional cohort. In doing so, they sought to assess which preoperative variables carried the most weight in driving the decision for intervention and could be used to guide future surgical decision-making through an evidence-based approach.
The authors reviewed the records of patients who had undergone evaluation by neurosurgery and otolaryngology with subsequent active treatment (resection or radiation) for unilateral VS in the period from 2009 to 2021, as well as those of patients who had been evaluated for VS and were managed conservatively throughout 2021. Clinical presentation, radiographic data, and management plans were abstracted from each patient record from the time of first evaluation until the last follow-up or surgery. Each encounter with the patient was treated as an instance involving a management decision that depended on demographics, symptoms, and tumor profile. Decision tree and random forest classifiers were trained and tested to predict the decision for treatment versus imaging surveillance on the basis of unseen data using an 80/20 pseudorandom split. Predictor variables were tuned to maximize performance based on lowest Gini impurity indices. Model performance was optimized using fivefold cross-validation.
One hundred twenty-four patients with 198 rendered decisions concerning management were included in the study. In the decision tree analysis, only a maximum tumor dimension threshold of 1.6 cm and progressive symptoms were required to predict the decision for treatment with 85% accuracy. Optimizing maximum dimension thresholds and including age at presentation boosted accuracy to 88%. Random forest analysis (n = 500 trees) predicted the decision for treatment with 80% accuracy. Factors with the highest variable importance based on multiple measures of importance, including mean minimal conditional depth and largest Gini impurity reduction, were maximum tumor dimension, age at presentation, Koos grade, and progressive symptoms at presentation.
Tree-based ML was used to predict which factors drive the decision for active treatment of VS with 80%-88% accuracy. The most important factors were maximum tumor dimension, age at presentation, Koos grade, and progressive symptoms. These results can assist in surgical decision-making and patient counseling. They also demonstrate the power of ML algorithms in extracting useful insights from limited data sets.
前庭神经鞘瘤(VSs)是成人桥小脑角最常见的肿瘤。尽管这些病变通常生长缓慢,但它们的生长模式和相关症状可能不可预测,这可能使保守治疗与积极干预之间的决策复杂化。此外,由于高质量证据有限和多种生活质量考虑因素,手术决策可能存在争议。机器学习(ML)是一种利用数据集将多维临床过程本质化的强大工具。在这项研究中,作者使用多个基于树的 ML 算法对单机构队列中的 VS 进行主动治疗与 MRI 监测的决策进行了训练。通过这样做,他们试图评估哪些术前变量对干预决策的影响最大,并通过循证方法指导未来的手术决策。
作者回顾了 2009 年至 2021 年间接受神经外科和耳鼻喉科评估并随后接受单侧 VS 主动治疗(切除或放疗)的患者记录,以及 2021 年期间接受 VS 评估并保守治疗的患者记录。从每位患者的首次评估到最后一次随访或手术,从每位患者的病历中提取临床表现、影像学数据和治疗计划。每次与患者的接触都被视为取决于人口统计学、症状和肿瘤特征的管理决策。使用 80/20 伪随机分割,基于未见数据,使用决策树和随机森林分类器对治疗与影像学监测的决策进行训练和测试。调整预测变量以最大限度地降低基尼杂质指数。使用五重交叉验证优化模型性能。
共纳入 124 例患者,共进行了 198 次管理决策。在决策树分析中,仅最大肿瘤尺寸阈值为 1.6cm 和进行性症状即可预测 85%的治疗决策。通过优化最大尺寸阈值并包括就诊时的年龄,准确性提高到 88%。随机森林分析(n=500 棵树)预测治疗决策的准确率为 80%。基于多种重要性度量的最重要变量是最大肿瘤尺寸、就诊年龄、Koos 分级和就诊时的进行性症状。
基于树的 ML 用于预测哪些因素可驱动 VS 积极治疗的决策,准确率为 80%-88%。最重要的因素是最大肿瘤尺寸、就诊年龄、Koos 分级和进行性症状。这些结果有助于手术决策和患者咨询。它们还展示了 ML 算法从有限数据集提取有用见解的能力。